Previous Close | 35.40 |
Open | 35.40 |
Bid | 28.65 |
Ask | 31.70 |
Strike | 105.00 |
Expire Date | 2025-01-17 |
Day's Range | 35.40 - 35.40 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease drugs.